Mitsubishi Tanabe Pharma America, Inc. announced RADICAVA ™ (edaravone), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis...
Read moreAbbVie , a global biopharmaceutical company announced that the EC has granted marketing authorization for MAVIRET® (glecaprevir/pibrentasvir), a once-daily, ribavirin-free...
Read moreThe EC has approved an update to the Victoza® (liraglutide) EU label that expands the indication to reflect both improving...
Read moreSamumed announced that the U.S. FDA has granted SM04646, a novel small molecule Wnt pathway inhibitor, an Orphan Drug Designation...
Read moreLexicon Pharmaceuticals, Inc. , announced that the Committee for Medicinal Products for Human Use (CHMP), the committee of the European...
Read morePersonalMed, LLC, has entered into a collaborative agreement with AmerisourceBergen’s pharmacy services administrative organization (PSAO), Elevate Provider Network, to introduce...
Read moreForensic scientists who need to differentiate genetic profiles in forensic DNA mixtures, such as those commonly associated with crime scenes,...
Read moreLEO Pharma announced that it appointed Chris Posner Executive Vice President Region US and President & CEO, LEO Pharma, Inc....
Read moreThe Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) of the FDA, has invited PharmaMar to participate in this ODAC,...
Read moreTeva Pharmaceutical Industries Ltd announced the launch of generic Glumetza®1 (metformin hydrochloride extended-release tablets), 500 mg and 1000 mg, in...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.